Gefitinib promising as second-line therapy for oesophageal cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1469, 2005-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Second-line drug therapy for osteoarthritis

By Brandt Kenneth D  

Clinical Medicine, Vol. 1, Iss. 2, 2001-03 ,pp. : 110-112

Royal College Of Physicians

Access to resources Recommend Favorite

Lenalidomide plus dexamethasone a winner as second-line therapy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 645, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Second-line quadruple therapy effective for H. pylori eradication

By  

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

An evaluation of pemetrexed in second-line treatment of non-small cell lung cancer

By Scagliotti Giorgio  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2855-2866

Informa Healthcare

Access to resources Recommend Favorite

Gastric and gastro-oesophageal cancer therapy

By Das Prajnan   Ajani Jaffer A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2805-2812

Informa Healthcare

Access to resources Recommend Favorite